Magnesiocard

Magnesium L-Aspartate Hydrochloride Trihydrate, the active ingredient in Magnesiocard, is a mineral supplement presented as an oral tablet for oral use. It helps restore normal magnesium levels and supports muscle and nerve function in adults, particularly when dietary intake is insufficient.

GNH USA supplies Magnesiocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesiocard provides magnesium supplementation for conditions related to low magnesium status. - Magnesium deficiency: replenishes systemic magnesium stores and normalises serum levels. - Muscle cramps: reduces frequency and intensity of involuntary muscle contractions. - Premenstrual syndrome (PMS): alleviates associated muscle tension and fatigue.

Magnesiocard may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Diarrhoea: loose stools occurring after oral intake. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas. - Metallic taste: transient alteration in oral sensation.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium leading to cardiac arrhythmia. - Allergic reaction: rash, itching, or swelling of the face. - Severe hypotension: marked drop in blood pressure. - Respiratory depression: slowed breathing in extreme cases.

When using Magnesiocard, consider the following safety measures. - Renal impairment: avoid or adjust dose in patients with reduced kidney function. - Concomitant medications: review potential interactions with other supplements or drugs. - Pregnancy: use only if clearly needed and prescribed by a healthcare professional. - Breastfeeding: consult a physician before use. - Elderly patients: monitor for signs of excess magnesium. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Magnesiocard can affect the absorption or activity of several medicines.

Major Interactions (Avoid): - Aminoglycoside antibiotics: may reduce antibacterial efficacy. - Bisphosphonates: concurrent use can impair absorption of both agents. - Tetracycline antibiotics: magnesium chelates reduce tetracycline bioavailability.

Moderate Interactions (Monitor Closely): - Loop and thiazide diuretics: may increase risk of electrolyte imbalance. - Proton pump inhibitors: can alter magnesium absorption over long term. - Calcium channel blockers: additive effect on cardiac conduction may require monitoring.